ANI Pharmaceuticals Q1 2026 Earnings Major EPS Beat Belies Subdued Market Response Regency Centers Corporation 625 Series A Cumulative Redeemable Preferred Stock REGCP Q1 2026 Earnings Strong EPS Beat Signals Steady Preferred Dividend Coverage ACTU Q1 2026 Earnings EPS Miss Weighs on Shares as Biotech Firm Navigates EarlyStage Pipeline VRME Q4 2025 Earnings EPS Misses Estimates as Stock Edges Lower Mainz Biomed NV Ordinary Shares Q4 2023 Earnings EPS Beat Estimate Despite Absence of Revenue Stock Declines SPRU Q1 2026 Earnings Negative EPS but Positive Market Momentum Amid Strategic Shift